TABLE 2.
Statistically significant differencesa between C. trachomatis infections in men and women with respect to serovar, genogroup, gender, age, symptomatic or asymptomatic course of infection, and clinical symptoms
| Variable(s) compared | Patient group, no./total (%)b | P value |
|---|---|---|
| Serovar, serogroup | ||
| Ga | M; Symp, 6/42 (14.3) vs Asymp, 0/66 (0) | 0.0027 |
| Ga | F + M; Symp, 7/142 (4.9) vs Asymp, 3/296 (1.0) | 0.016d |
| Ia | F + M; Symp, 0/142 (0) vs Asymp, 9/296 (3.0) | 0.035 |
| Intermediate | M; Symp, 18/42 (43) vs Asymp, 15/66 (23) | 0.033d |
| Specific symptoms of infection | ||
| K | F; Vag. dis., 6/38 (10.3) vs No vag. dis., 7/274 (2.6) | 0.002 |
| Ga | M; Dysuria, 6/24 (25) vs No dysuria 0/84 (0) | <0.0001 |
| CT, gender | ||
| Ga | Symp M, 6/42 (14.3) vs Symp F, 1/100 (1.0) | 0.0028 |
| Variants | F, 13/330 (3.9) vs M, 0/108 (0) | 0.045 |
| Age, 15–19-yr-old | Symp F, 15/97 (15.5) vs Asymp F, 13/225 (5.8) | 0.0084 |
a
All other associations between C. trachomatis serovars or genogroups and a symptomatic or asymptomatic course of infection were not statistically significant.
b
M, male; F, female; Symp, symptomatic; Asymp, asymptomatic; Vag. dis., vaginal discharge.